What Researchers Did
Researchers conducted a multicenter prospective study comparing hyperbaric oxygen therapy plus iloprost to a historical cohort receiving iloprost alone for severe frostbite.
What They Found
The prospective cohort (28 patients) receiving HBO plus iloprost had a significantly higher mean number of preserved segments per patient (13 ± 10) compared to the historical cohort (30 patients) receiving iloprost alone (6 ± 5, p = 0.006). The odds of preserving segments were 45-fold higher (95%CI: 6-335, p < 0.001) in the HBO plus iloprost group.
What This Means for Canadian Patients
For Canadian patients experiencing severe frostbite, this study suggests that adding hyperbaric oxygen therapy to standard iloprost treatment could significantly improve the chances of preserving affected digits. This approach may lead to better functional outcomes and reduce the need for amputations, potentially improving quality of life.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a cross-border program among hyperbaric centers in Geneva, Lyon, and Mont-Blanc hospitals.
Study Limitations
A significant limitation is the comparison to a historical cohort rather than a concurrently randomized control group, which introduces potential biases.